Stress erythropoiesis: definitions and models for its study.


Journal

Experimental hematology
ISSN: 1873-2399
Titre abrégé: Exp Hematol
Pays: Netherlands
ID NLM: 0402313

Informations de publication

Date de publication:
09 2020
Historique:
received: 24 04 2020
revised: 28 07 2020
accepted: 30 07 2020
pubmed: 5 8 2020
medline: 15 12 2020
entrez: 5 8 2020
Statut: ppublish

Résumé

Steady-state erythropoiesis generates new erythrocytes at a constant rate, and it has enormous productive capacity. This production is balanced by the removal of senescent erythrocytes by macrophages in the spleen and liver. Erythroid homeostasis is highly regulated to maintain sufficient erythrocytes for efficient oxygen delivery to the tissues, while avoiding viscosity problems associated with overproduction. However, there are times when this constant production of erythrocytes is inhibited or is inadequate; at these times, erythroid output is increased to compensate for the loss of production. In some cases, increased steady-state erythropoiesis can offset the loss of erythrocytes but, in response to inflammation caused by infection or tissue damage, steady-state erythropoiesis is inhibited. To maintain homeostasis under these conditions, an alternative stress erythropoiesis pathway is activated. Emerging data suggest that the bone morphogenetic protein 4 (BMP4)-dependent stress erythropoiesis pathway is integrated into the inflammatory response and generates a bolus of new erythrocytes that maintain homeostasis until steady-state erythropoiesis can resume. In this perspective, we define the mechanisms that generate new erythrocytes when steady-state erythropoiesis is impaired and discuss experimental models to study human stress erythropoiesis.

Identifiants

pubmed: 32750404
pii: S0301-472X(20)30305-2
doi: 10.1016/j.exphem.2020.07.011
pmc: PMC7508762
mid: NIHMS1624452
pii:
doi:

Substances chimiques

BMP4 protein, human 0
Bone Morphogenetic Protein 4 0
Cytokines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-54.e2

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK080040
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK119865
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL146528
Pays : United States
Organisme : NIDDK NIH HHS
ID : R56 DK080040
Pays : United States

Informations de copyright

Copyright © 2020 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Références

Curr Top Dev Biol. 2008;82:23-53
pubmed: 18282516
Blood. 2011 Sep 1;118(9):2578-88
pubmed: 21725055
Trends Mol Med. 2018 Mar;24(3):304-318
pubmed: 29433944
Blood. 2015 Mar 12;125(11):1803-12
pubmed: 25608563
J Clin Invest. 1968 Oct;47(10):2230-8
pubmed: 5676519
Science. 2008 Dec 19;322(5909):1839-42
pubmed: 19056937
Blood. 2019 Aug 1;134(5):480-491
pubmed: 31101625
Transfus Clin Biol. 2010 Sep;17(3):110-1
pubmed: 20655267
Exp Hematol. 2016 Mar;44(3):207-12.e4
pubmed: 26607596
Proc Natl Acad Sci U S A. 1978 Jun;75(6):2937-40
pubmed: 96444
Cancer Manag Res. 2011;3:211-7
pubmed: 21792329
Haematologica. 2015 Nov;100(11):1396-406
pubmed: 26294724
Exp Hematol. 2019 Oct;78:21-34.e3
pubmed: 31562902
Blood Rev. 2019 Jan;33:11-23
pubmed: 30616747
Blood. 2000 Jun 15;95(12):3716-24
pubmed: 10845902
Exp Hematol. 2014 May;42(5):404-409.e4
pubmed: 24463276
Mol Ther Methods Clin Dev. 2017 Nov 21;8:75-86
pubmed: 29276718
Exp Hematol. 2004 May;32(5):483-93
pubmed: 15145217
Dis Model Mech. 2019 Sep 6;12(9):
pubmed: 31519693
Exp Hematol. 2020 Jan;81:16-31.e4
pubmed: 31887343
Front Immunol. 2017 Sep 20;8:1140
pubmed: 28979259
Blood Adv. 2019 Jul 23;3(14):2205-2217
pubmed: 31324641
Blood. 2019 Jan 3;133(1):40-50
pubmed: 30401705
Nature. 2015 Jun 25;522(7557):474-7
pubmed: 25970251
Cells. 2020 Mar 06;9(3):
pubmed: 32155728
EMBO Rep. 2002 Jun;3(6):569-74
pubmed: 12034755
Nat Med. 2013 Apr;19(4):429-36
pubmed: 23502962
J Exp Med. 2020 Sep 7;217(9):
pubmed: 32520308
Annu Rev Immunol. 2013;31:563-604
pubmed: 23516985
J Clin Invest. 2010 Dec;120(12):4507-19
pubmed: 21060151
Mol Med Rep. 2016 Jan;13(1):587-91
pubmed: 26648325
Blood. 2014 Feb 20;123(8):1129-36
pubmed: 24357728
Br J Haematol. 2018 Mar;180(5):630-643
pubmed: 29193029
Adv Genet. 1979;20:357-459
pubmed: 390999
Haematologica. 2016 May;101(5):e164-7
pubmed: 26944471
Stem Cells Dev. 2012 Oct 10;21(15):2852-65
pubmed: 22533504
J Exp Med. 2004 Jan 19;199(2):221-9
pubmed: 14718516
Blood. 2010 Dec 23;116(26):6072-81
pubmed: 20844235
Blood. 2012 Sep 13;120(11):2203-13
pubmed: 22855602
Exp Hematol. 1977 May;5(3):161-5
pubmed: 872906
EMBO Rep. 2015 Nov;16(11):1482-500
pubmed: 26474900
Nat Cell Biol. 2016 Jun;18(6):607-18
pubmed: 27111842
Nature. 2014 Oct 16;514(7522):322-7
pubmed: 25296256
Am J Hematol. 1993 Jan;42(1):91-5
pubmed: 7677951
J Clin Invest. 2015 Oct 1;125(10):3965-80
pubmed: 26389678
Cell Host Microbe. 2013 May 15;13(5):509-519
pubmed: 23684303
J Exp Med. 2014 Feb 10;211(2):181-8
pubmed: 24493804
Blood. 2006 Jul 15;108(2):726-33
pubmed: 16537808
Cell Mol Life Sci. 2020 Jul;77(14):2723-2738
pubmed: 31974657
Exp Hematol. 1977 Mar;5(2):141-8
pubmed: 844518
Blood. 2014 Feb 20;123(8):1137-45
pubmed: 24357729
Blood. 2009 Jan 22;113(4):911-8
pubmed: 18927434
Br J Haematol. 1986 Jul;63(3):415-24
pubmed: 3524655
Blood. 2002 Jul 15;100(2):474-82
pubmed: 12091338
Immunol Res. 2015 Dec;63(1-3):75-89
pubmed: 26376896
Exp Hematol. 2002 Nov;30(11):1238-47
pubmed: 12423676
Dev Comp Immunol. 1984 Winter;8(1):169-78
pubmed: 6539258
Med Clin North Am. 1992 May;76(3):649-68
pubmed: 1578962
Methods Mol Biol. 2018;1717:161-187
pubmed: 29468592
Blood. 2017 Oct 12;130(15):1693-1698
pubmed: 28874349
Blood. 2012 May 17;119(20):4741-51
pubmed: 22461491
Blood. 1999 Jul 15;94(2):550-9
pubmed: 10397722
Cell. 2018 Apr 5;173(2):430-442.e17
pubmed: 29606353
Blood. 2019 Mar 14;133(11):1222-1232
pubmed: 30674470
Int J Hematol. 2018 Jul;108(1):5-21
pubmed: 29380178
Exp Hematol. 2008 Dec;36(12):1604-1615
pubmed: 18973974
Nature. 2018 Mar 1;555(7694):54-60
pubmed: 29466336
Cell Stem Cell. 2007 Oct 11;1(4):428-42
pubmed: 18371379
J Immunol. 2010 Nov 15;185(10):6198-204
pubmed: 20952675
J Exp Med. 2011 Jun 6;208(6):1189-201
pubmed: 21555486
Exp Hematol. 1982 May;10(5):478-85
pubmed: 6284534
Curr Opin Hematol. 2015 May;22(3):212-9
pubmed: 25693142
Am J Hematol. 1976;1(4):453-8
pubmed: 1008057
Br J Haematol. 2013 Aug;162(4):542-6
pubmed: 23713742
Blood. 2008 Aug 1;112(3):470-8
pubmed: 18650462
Curr Opin Hematol. 2011 May;18(3):139-45
pubmed: 21372709
Haematologica. 2018 Mar;103(3):395-405
pubmed: 29284682
Nature. 2013 Jul 4;499(7456):92-6
pubmed: 23748442
Nature. 2015 Feb 26;518(7540):542-6
pubmed: 25686605
Blood. 2005 Apr 1;105(7):2741-8
pubmed: 15591122
Semin Ultrasound CT MR. 2014 Jun;35(3):255-62
pubmed: 24929265
Nat Immunol. 2019 May;20(5):626-636
pubmed: 30936495
Front Immunol. 2020 Mar 13;11:454
pubmed: 32231672
Blood. 2020 Jul 9;136(2):235-246
pubmed: 32350523
Blood Rev. 2018 Mar;32(2):130-143
pubmed: 29054350
Exp Hematol. 2009 May;37(5):549-58
pubmed: 19375646
Exp Hematol. 2014 Jul;42(7):547-61.e4
pubmed: 24721610
Stem Cells. 1982;1(3):165-79
pubmed: 7178998
Nat Genet. 2007 Oct;39(10):1197-9
pubmed: 17767159
Stem Cell Reports. 2018 Jun 5;10(6):1908-1919
pubmed: 29754961
Exp Hematol. 1998 Mar;26(3):222-7
pubmed: 9502618
Blood. 2014 May 15;123(20):3080-8
pubmed: 24652993
Am J Hematol. 1989 Oct;32(2):123-8
pubmed: 2757009
Methods Mol Biol. 2018;1698:91-102
pubmed: 29076085
J Trauma Acute Care Surg. 2017 Jul;83(1):144-150
pubmed: 28452894
Front Physiol. 2014 Jan 28;5:3
pubmed: 24478716
Exp Hematol. 2000 Dec;28(12):1343-53
pubmed: 11146156
Haematologica. 2015 Feb;100(2):178-87
pubmed: 25533803
Blood. 2018 Aug 16;132(7):735-749
pubmed: 29945953
Curr Opin Pharmacol. 2015 Dec;25:62-6
pubmed: 26654865
Nature. 2018 Jan 11;553(7687):212-216
pubmed: 29323290
Nat Immunol. 2018 Jan;19(1):85-97
pubmed: 29167569
EMBO J. 1997 Jan 15;16(2):267-80
pubmed: 9029148
Nat Med. 2013 Apr;19(4):437-45
pubmed: 23502961
Cell Stem Cell. 2014 Apr 3;14(4):445-459
pubmed: 24561084
Front Immunol. 2017 Feb 02;8:73
pubmed: 28210260
Hum Gene Ther. 2016 Apr;27(4):287-94
pubmed: 27018965
Front Immunol. 2020 Jan 31;11:66
pubmed: 32082323
Blood. 2018 Dec 13;132(24):2580-2593
pubmed: 30322871
Sci Signal. 2019 Sep 10;12(598):
pubmed: 31506384
Blood. 2003 Nov 1;102(9):3136-46
pubmed: 12869505
Nat Rev Immunol. 2017 Mar;17(3):165-178
pubmed: 28163303
Blood. 1976 Dec;48(6):843-53
pubmed: 793650
Genes Dev. 1999 Nov 15;13(22):2996-3002
pubmed: 10580006
Blood. 2011 Jan 20;117(3):975-85
pubmed: 20956802
Mol Med. 2016 May;21(1):951-958
pubmed: 26736178
Blood. 2007 May 15;109(10):4494-502
pubmed: 17284534
Nat Biotechnol. 2016 Sep 8;34(9):893-4
pubmed: 27606442
Rev Hematol. 1958 Jan-Mar;13(1):8-11
pubmed: 13555228
Bone Marrow Transplant. 1994 Nov;14(5):737-40
pubmed: 7534160

Auteurs

Robert F Paulson (RF)

Center for Molecular Immunology and Infectious Disease and the Department of Veterinary and Biomedical Sciences, Penn State University, University Park, PA; Intercollege Graduate Program in Genetics, Penn State University, University Park, PA. Electronic address: rfp5@psu.edu.

Sneha Hariharan (S)

Intercollege Graduate Program in Genetics, Penn State University, University Park, PA.

Jane A Little (JA)

Department of Medicine, University of North Carolina Comprehensive Sickle Cell Disease Program, Chapel Hill, NC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH